Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1993 Aug;42(2):131-5.
doi: 10.1016/0020-7292(93)90626-8.

Intravesical formalin for hemorrhagic cystitis following irradiation of cancer of the cervix

Affiliations
Clinical Trial

Intravesical formalin for hemorrhagic cystitis following irradiation of cancer of the cervix

A K Dewan et al. Int J Gynaecol Obstet. 1993 Aug.

Abstract

Objective: To determine the effectiveness of intravesical formalin instillation in hemorrhagic cystitis following irradiation of cancer of the cervix.

Method: Records were reviewed for 35 patients with hemorrhagic radiation cystitis who underwent treatment with 1% (n = 22), 2% (n = 10), and 4% formalin (n = 4), using Fair's technique.

Result: Complete response was seen in 31 patients (89%) and partial response in 3 patients (8%) after a single instillation. Minor complications were seen in 19 patients (54%). Major complications occurred in 11 patients (31%), with 5 cases requiring subsequent urinary diversion. One patient died of persistent bleeding and probable formalin toxicity. Hematuria recurred in 7 patients achieving complete response at a mean period of 8 months after treatment. A 1% solution was as effective in controlling hematuria as higher concentrations and was associated with significantly less morbidity.

Conclusion: Intravesical instillation of 1% formalin is an effective treatment for intractable hematuria secondary to radiation cystitis.

PubMed Disclaimer

Publication types